Abstract: AbstractBackgroundRespiratory failure is the main cause of mortality and morbidity among ICU patients with coronavirus disease 2019 (COVID‐19). In these patients, supplemental oxygen therapy is essential, but there is limited evidence the optimal target. To address this, the ongoing handling oxygenation targets in COVID‐19 (HOT‐COVID) trial was initiated to investigate the effect of a lower oxygenation target (partial pressure of arterial oxygen (PaO2) of 8 kPa) versus a higher oxygenation target (PaO2 of 12 kPa) in the ICU on clinical ou...
(read more)
Topics: 
Intensive care medicine
Anesthesia
Internal medicine